Recombinant Human RGS1 Protein，His

RGS1 (Regulator of G-protein Signaling 1) is a crucial adaptor protein that plays a significant role in modulating G-protein-coupled receptor (GPCR) signaling pathways, which are essential for various physiological processes including immune responses and cell growth. Research into RGS1 has gained prominence due to its implications in diverse biological functions and potential therapeutic applications. This protein serves as a GTPase-activating protein, accelerating the hydrolysis of GTP bound to Gα subunits, thus terminating the signaling cascade initiated by GPCR activation. Abnormal expression or activity of RGS1 has been linked to several diseases, including cancer, autoimmune disorders, and cardiovascular conditions, making it a target of interest for drug discovery. Additionally, RGS1 is known to interact with various cellular partners, influencing downstream signaling pathways and cellular responses. Understanding the structure and function of RGS1, along with the development of recombinant forms of the protein, is critical for elucidating its role in health and disease. The generation of recombinant RGS1 protein allows researchers to study its biochemical properties, interaction networks, and functional dynamics in a controlled environment, facilitating the identification of potential therapeutic interventions that could modify its activity. As such, exploring the biochemistry and pharmacology of RGS1 represents a vital area of research with the potential to unlock novel strategies for treating diseases linked to dysregulated GPCR signaling.